Browse by category

LUCIDITY trial to assess Avexitide in post-bariatric hypoglycaemia patients

Amylyx Pharmaceuticals plans to initiate a Phase 3 LUCIDITY clinical trial for avexitide, an investigational, first-in-class...

PREVENT Study: Positive results of Avexitide in post-bariatric hypoglycaemia patients

Eiger BioPharmaceuticals has announced positive results from the Phase 2 PREVENT study of Avexitide in patients with severe...

Reduced complication-related costs and enhanced patient recovery using the Ezisurg Endostapler

14 hours ago

Fractyl unveils promising preclinical data demonstrating safety and feasibility of local delivery of RJVA-001 Rejuva Smart GLP-1 Pancreatic Gene Therapy

4 days ago

Researchers to develop BIOSYNC wireless bioelectronic device to treat obesity and diabetes

5 days ago

Browse by category

Browse by tag

Weekly Digest

Get a round-up of the main headlines from Bariatric News, directly to your inbox each week.

Get in touch!
Email: info@bariatricnews.net